Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability and Immunogenicity of Fluval AB Influenza Vaccine in Adults and Elderly
NCT01863849Phase 4Completed
- Sponsor
- Fluart Innovative Vaccines
- Start
- Aug 2013
- Primary completion
- Sep 2013
- Modality
- Prophylactic Vaccines
- Countries
- 1
01
Overview
Phase 4, open-label trial of Fluval AB vaccine in influenza (2 arms), sponsored by Fluart Innovative Vaccines. Primary endpoints: Change in Geometric Mean Titre Ratio, Seroconversion and 1 more. Started Aug 2013; status: completed.
02
Drugs
Fluval AB vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01863849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01863849.